NCT03770936招募中3 期
Clinical Study Evaluating the Efficacy of Renin Angiotensin System Inhibitors on the Extent of Liver Fibrosis in Patients With Chronic Hepatitis C
Sherief Abd-Elsalam1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2018年10月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 45
- 试验地点
- 1
- 主要终点
- Change in Fibroscan or APRI score
研究概览
简要总结
Effect of Some Drugs on Liver Fibrosis
详细描述
The study aimed at evaluating the effect of Some Drugs on Liver Fibrosis
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •chronic hepatitis C
排除标准
- •Acute hepatitis
- •Thalassemia
研究组 & 干预措施
Candesartan
Active Comparator
Candesartan 8 mg/day
干预措施: Candesartan (Drug)
Ramipril
Active Comparator
Ramipril 1.25 mg/day
干预措施: Ramipril (Drug)
结局指标
主要结局
Change in Fibroscan or APRI score
时间窗: 6 months
Change in Fibroscan or APRI score
次要结局
未报告次要终点
研究者
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Tanta University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Prospective Evaluation of FibroScan in Patients Treated With MethotrexateLiver FibrosisNCT00673101Association HGE CHU Bordeaux Sud1,871
招募中
不适用
Efficacy of liver stiffness measurement by ultrasonography in pediatric liver diseasesPediatric liver diseaseJPRN-jRCTs042190056Honda Takashi200
尚未招募
不适用
Study for the correlation between liver fibrosis evaluated by using abdominal ultrasonography and prognosis in pediatric patients with liver diseasespediatric liver diseasesJPRN-UMIN000033123agoya University graduate school of medicine department of gastroenterology and hepatology200
招募中
不适用
Study for the correlation between liver fibrosis, steatosis and prognosis of the patients by using abdominal ultrasonographyliver diseaseJPRN-UMIN000031374agoya University4,000
已完成
3 期
Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis CHepatitis C, ChronicNCT00265642ANRS, Emerging Infectious Diseases166